Recent Finacing
Recent Raise
至本医疗科技 provides comprehensive multi‑gene NGS tests for solid tumors, proprietary bioinformatics and a China-focused tumor/clinical/drug database, a precision-treatment app, CAP‑certified lab, and hospital clinical partnerships.
